Synthego Acquired by Perceptive Advisors, Solidifying Commitment to CRISPR Solutions

Synthego, a prominent CRISPR solutions provider, has been acquired by Perceptive Advisors, a leading life sciences investment firm. Despite the ownership change, Synthego will maintain its operations and commitment to delivering top-quality CRISPR products and global clientele support.